Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
In The Medicines Company v. Hospira, Inc., App. No. 14-1469, 14-1504 (Fed. Cir. July 11, 2016) (slip op.) (en banc), the Federal Circuit provided clarity and guidance to companies that rely on contract manufacturing, holding that “to be 'on sale' under '102(b), a product must be the subject of a commercial sale or offer for sale, and that a commercial sale is one that bears the general hallmarks of a sale pursuant to Section 2-106 of the Uniform Commercial Code.” Id. at 3.
The case arose in the context of Hospira's Abbreviated New Drug Application (ANDA) submissions seeking FDA approval to sell generic versions of The Medicines Company's (TMC) Angiomax', an anticoagulant used in heart surgery. In the ensuing litigation, alleging that Hospira's ANDA submissions infringed two of TMC's patents, Hospira raised several grounds of invalidity, including that TMC's inventions were sold or offered for sale before the critical date under '102(b).
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
Blockchain domain names offer decentralized alternatives to traditional DNS-based domain names, promising enhanced security, privacy and censorship resistance. However, these benefits come with significant challenges, particularly for brand owners seeking to protect their trademarks in these new digital spaces.